Friday, May 22, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Trends

More Than a Pop Star Problem: Miley Cyrus, Ovarian Cysts, and the Silence Around Gynecological Pain

Miley Cyrus’s revelation of an “excruciating” ovarian cyst rupture sparked viral headlines—but behind the celebrity story lies a broader issue: the under-recognition of gynecological pain in medicine and society.

Ashley Rodgers by Ashley Rodgers
May 29, 2025
in Politics & Law
0

It wasn’t a red carpet moment, but it made headlines just the same.

In a candid interview, pop icon Miley Cyrus revealed she had experienced an “excruciating” ovarian cyst rupture—an intensely painful, often underreported gynecological event that affects millions of women but rarely commands serious attention. Her admission, both vulnerable and unfiltered, struck a nerve: not just because of who she is, but because of how rarely public figures speak frankly about reproductive pain.

Ovarian cysts are remarkably common, and yet the suffering they cause often slips through the cracks of both pop culture and clinical practice. Cyrus’s revelation cast a spotlight on a medical issue that continues to be minimized, misdiagnosed, and misunderstood—an issue that says as much about healthcare as it does about celebrity.

What Is an Ovarian Cyst—and Why It Matters

An ovarian cyst is a fluid-filled sac that develops on or inside an ovary. Most are benign and asymptomatic, but others can rupture, twist (a condition known as ovarian torsion), or cause significant bleeding and pain.

According to the Cleveland Clinic, ovarian cysts affect a majority of women at some point during their reproductive years. Yet because symptoms—pelvic pain, bloating, irregular periods—overlap with many other conditions, cysts are frequently dismissed or misdiagnosed.

That misdiagnosis can be costly. A ruptured cyst can mimic appendicitis or ectopic pregnancy and, in rare cases, may lead to hemorrhage and emergency surgery. Despite these risks, women reporting such pain are often met with skepticism or told they’re overreacting.

Miley Cyrus’s choice to name the pain—publicly—stands in sharp contrast to the medical system’s long-standing habit of silencing it.

The Diagnostic Dismissal of Women’s Pain

The phenomenon isn’t new. Studies have consistently shown that women’s pain is often taken less seriously than men’s. A landmark study in Academic Emergency Medicine found that women presenting with abdominal pain waited 33% longer than men to receive analgesics in the ER.

When it comes to reproductive pain—such as that from endometriosis, fibroids, or ovarian cysts—the problem is even more acute. These conditions often require imaging, specialist referrals, or laparoscopy to confirm—but are frequently reduced to “menstrual cramps” or anxiety in routine clinical encounters.

In pop culture, that erasure is compounded. Gynecological suffering is either played for laughs or completely ignored. Until a star like Cyrus says otherwise.

The Power of Celebrity Disclosure

Celebrities have long influenced health narratives—Angelina Jolie’s BRCA gene testing, Selena Gomez’s lupus diagnosis, even Michael J. Fox’s Parkinson’s advocacy. When a figure like Miley Cyrus discusses ovarian pain, it elevates the issue into mainstream conversation.

According to Healthline, online searches for “ovarian cyst symptoms” spiked after Cyrus’s interview. That spike, while fleeting, reflects something powerful: public validation for silent suffering.

But it also raises questions. Why does it take celebrity pain to draw attention to ordinary experiences? Why must a famous body become the proving ground for medical legitimacy?

The answer is complex—but ultimately rooted in how deeply society underestimates female health concerns.

A Public Health Issue Hiding in Plain Sight

Ovarian cysts are part of a broader pattern of reproductive neglect. Endometriosis affects 1 in 10 women of reproductive age and takes an average of 8 years to diagnose. Polycystic ovary syndrome (PCOS) affects 1 in 5 and is linked to infertility, metabolic disorders, and mental health issues—yet remains vastly underdiagnosed.

These are not fringe conditions. They are population-level health burdens. And they are routinely overlooked.

Part of the problem lies in education. Many women are not taught to recognize what abnormal pain looks like, and many providers are not trained to look beyond basic symptoms. A 2020 study in BMJ Open found that only 35% of general practitioners felt confident managing gynecological pain without a specialist.

The system, in other words, is not just under-informed. It is underprepared.

The Need for a Cultural and Clinical Shift

To move forward, we need more than awareness. We need accountability.

That means increasing investment in women’s health research, which currently receives less than half the funding of male-dominated disease areas. It means revising medical school curricula to prioritize pain equity and reproductive diagnostics. And it means listening—really listening—to patients when they describe their pain.

Public figures can help normalize the conversation. But structural change must follow.

Conclusion: From Pain to Power

Miley Cyrus didn’t ask to become a spokesperson for ovarian cysts. But her choice to speak out disrupted a silence that has gone on too long.

Her story is not unique. It is, in fact, painfully common. But in the echo of her words, there’s a call—to patients, to providers, to policymakers—to stop treating gynecological pain as a footnote.

Because for too many women, the pain is real, the diagnosis is delayed, and the silence is deadly.

It’s time to listen.

And more importantly, it’s time to act.

ShareTweet
Ashley Rodgers

Ashley Rodgers

Ashley Rodgers is a writer specializing in health, wellness, and policy, bringing a thoughtful and evidence-based voice to critical issues.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The IRA’s Drug Negotiation Mechanism Meets the Rebate Industrial Complex

    The IRA’s Drug Negotiation Mechanism Meets the Rebate Industrial Complex

    0 shares
    Share 0 Tweet 0
  • One Dose, Many Decades

    0 shares
    Share 0 Tweet 0
  • The Price Is Right, Theoretically: What Turquoise Health Actually Reveals About Hospital Markets

    0 shares
    Share 0 Tweet 0
  • Two Platforms, Two Theories of Change in Hospital Pricing

    0 shares
    Share 0 Tweet 0
  • Infinite Clinical Games

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy